Concepedia
Statistics
Publications
48
Citations
1.5K
H-Index
21
Active since
1958
Affiliations
SRI International(Current)
Menlo School
Memorial Sloan Kettering Cancer Center
Stanford University
Southern Research Institute
Joseph I. DeGraw is an author at SRI International specializing in medicinal chemistry, pharmacology, and medicine.
Publications per year
1958–1998
New folate analogs of the 10-deaza-aminopterin series Basis for structural design and biochemical and pharmacologic properties
Francis M. Sirotnak, Joseph I. DeGraw, D. M. Moccio et al. · Cancer Chemotherapy and Pharmacology · 1984 · 143 citations
Pharmacy, Medicinal Chemistry, Pharmacology +12
New folate analogs of the 10-deaza-aminopterin series
Francis M. Sirotnak, Joseph I. DeGraw, Franz A. Schmid et al. · Cancer Chemotherapy and Pharmacology · 1984 · 137 citations
Pharmacy, Biochemistry, Medicinal Chemistry +9
A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice
Francis M. Sirotnak, Joseph I. DeGraw, William T. Colwell et al. · Cancer Chemotherapy and Pharmacology · 1998 · 92 citations
Medicine, Medicinal Chemistry, Pharmacology +6
Synthesis and antifolate properties of 5,10-ethano-5,10-dideazaaminopterin
Joseph I. DeGraw, P. H. Christie, William T. Colwell et al. · Journal of Medicinal Chemistry · 1992 · 77 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +7
New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
Franz A. Schmid, F. M. Sirotnak, Glenys M. Otter et al. · PubMed · 1985 · 69 citations
Medicine, Medicinal Chemistry, Pharmacology +9
1–5 of 48